Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | aspartyl protease ASP1 | 0.0441 | 0 | 0.5 |
Brugia malayi | Pepsin A precursor | 0.0441 | 0 | 0.5 |
Plasmodium vivax | aspartyl protease, putative | 0.0441 | 0 | 0.5 |
Toxoplasma gondii | aspartyl protease | 0.0441 | 0 | 0.5 |
Plasmodium vivax | aspartyl protease, putative | 0.0441 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin III | 0.0441 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin VIII, putative | 0.0441 | 0 | 0.5 |
Toxoplasma gondii | eukaryotic aspartyl protease superfamily protein | 0.0441 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin VII | 0.0441 | 0 | 0.5 |
Trypanosoma brucei | squalene synthase, putative | 0.3395 | 0.2802 | 0.5 |
Brugia malayi | hypothetical protein | 0.0441 | 0 | 0.5 |
Echinococcus multilocularis | Squalene phytoene synthase | 0.1058 | 0.0585 | 1 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.0441 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin IV | 0.0441 | 0 | 0.5 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0441 | 0 | 0.5 |
Brugia malayi | aspartic protease BmAsp-1, identical | 0.0441 | 0 | 0.5 |
Plasmodium vivax | plasmepsin IV, putative | 0.0441 | 0 | 0.5 |
Plasmodium vivax | aspartyl protease, putative | 0.0441 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin V | 0.0441 | 0 | 0.5 |
Echinococcus granulosus | Squalene phytoene synthase | 0.1058 | 0.0585 | 1 |
Schistosoma mansoni | hypothetical protein | 0.1058 | 0.0585 | 0.0585 |
Mycobacterium ulcerans | phytoene synthase, CrtB | 0.1058 | 0.0585 | 0.5 |
Onchocerca volvulus | NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 homolog | 0.1058 | 0.0585 | 1 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0441 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable phytoene synthase PhyA | 0.1058 | 0.0585 | 0.5 |
Brugia malayi | hypothetical protein | 0.0441 | 0 | 0.5 |
Brugia malayi | Eukaryotic aspartyl protease family protein | 0.0441 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin IX | 0.0441 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin I | 0.0441 | 0 | 0.5 |
Brugia malayi | aspartic protease BmAsp-2, identical | 0.0441 | 0 | 0.5 |
Leishmania major | squalene synthase, putative | 0.3395 | 0.2802 | 1 |
Plasmodium vivax | plasmepsin V, putative | 0.0441 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin VI | 0.0441 | 0 | 0.5 |
Toxoplasma gondii | aspartyl protease ASP3 | 0.0441 | 0 | 0.5 |
Trypanosoma cruzi | squalene synthase, putative | 0.3395 | 0.2802 | 1 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0441 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin X | 0.0441 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin II | 0.0441 | 0 | 0.5 |
Trypanosoma cruzi | squalene synthase, putative | 0.3395 | 0.2802 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1058 | 0.0585 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.